← All organizations

Biocompatibles International plc

For profit

Also known as: Biocompatibles UK Ltd

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 3

First clinical trial

Last known activity

Dec 31, 2021

Acquired by BTG → Boston Scientific Corporation on Jan 1, 2010

Timeline

1980s

Jan 1, 1984
Biocompatibles International plc— Founded

2010s

Jan 1, 2010
BTG— Acquired By
Nov 20, 2018
Boston Scientific Corporation— Now

Drugs by trial phase (13 distinct, 12 trials)

Phase 3 (2 own, 0 via acquisition)

Phase 2 (10 own, 0 via acquisition)

Phase 1 (1 own, 0 via acquisition)

vandetanib

Indications

Studied for

Recent trials (12)

NCT05063565CollaboratorPhase 2Dec 31, 2021
NCT04701918CollaboratorPhase 2Jun 4, 2021
NCT04108481CollaboratorPhase 1/Phase 2Oct 31, 2019
NCT03291379Lead sponsorEarly Phase 1May 17, 2017
NCT01887717CollaboratorPhase 3Jun 1, 2013
NCT01839877CollaboratorPhase 2May 1, 2013
NCT01631539CollaboratorN/ASep 1, 2012
NCT01060423CollaboratorPhase 2Feb 1, 2010
NCT00932438CollaboratorPhase 1/Phase 2Jun 1, 2009
NCT00844883CollaboratorPhase 2Feb 1, 2009
NCT00816777CollaboratorPhase 1/Phase 2Dec 1, 2008
NCT00877071CollaboratorPhase 2Nov 1, 2008

Details

Founded: Farnham, GB Jan 1, 1984
Last known activity: Dec 31, 2021